Skip to main content

Alpha 1-Proteinase Inhibitor Dosage

Medically reviewed by Last updated on Sep 18, 2023.

Applies to the following strengths: human

Usual Adult Dose for Alpha-1 Proteinase Inhibitor Deficiency

60 mg/kg intravenously once a week


Use: Chronic augmentation and maintenance therapy in adults with clinical evidence of emphysema due to hereditary deficiency of Alpha 1-Proteinase Inhibitor (alpha 1-antitrypsin deficiency)

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available



Safety and efficacy have not been established in patients younger than 18 years.

Report all infections thought by a physician to possibly be from this drug to the manufacturer or the FDA at

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

Administration advice:

Storage requirements:

Reconstitution/preparation techniques:

IV compatibility:


Patient advice:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.